期刊文献+

晚期口腔鳞癌术后患者放化疗临床分析

在线阅读 下载PDF
导出
摘要 目的:观察晚期口腔鳞癌患者切除术后给予放化疗的效果与患者的生存情况。方法:入选局部晚期口腔鳞癌患者共78例,随机分为观察组与对照组各39例,均给予总剂量为50Gy的放疗方案。观察组在放疗同时给予DDP 15mg/(m2.周)化疗,但对照组不给予化疗,比较两组的疗效与生存情况。结果:随访3年,其中观察组与对照组2年的局部控制率分别为55.34%和43.28%,差异具有统计学意义(P=0.039),3年的无瘤生存率分别为37.46%和26.61%(P=0.043),3年总生存率分别为46.87%及42.35%(P=0.106)。3年局部复发率分别为20.12%和34.95%(P=0.041),3年远处转移率分别为22.65%及28.29%(P=0.487)。两组的骨髓抑制(Ⅲ~Ⅳ级)发生率分别为37.19%和16.92%(P=0.006);两组的放射性黏膜损伤发生率分别为53.18%和27.82%(P=0.010)。结论:放化疗可显著提高晚期口腔鳞癌患者切除术后的疗效,且可降低副作用的发生率,但未能明显改善总生存率及远处转移率。
作者 余畅
出处 《长治医学院学报》 2013年第4期292-294,共3页 Journal of Changzhi Medical College
  • 相关文献

参考文献11

  • 1Harada H,Omura K,Tomioka H,et al.Multicenter phase Ⅱtrial of preoperative chemoradiotherapy with S-1 for locally advanced oral squamous cell carcinoma[J].Cancer Chemother Pharmacol,2013,71 (4):1059-1064.
  • 2Park G,Lee SW,Kim SY,et al.Can concurrent chemoradio-therapy replace surgery and postoperative radiation for locally advanced stage Ⅲ/Ⅳ tonsillar squamous cell carcinoma[J].Anticancer Res,2013,33(3):1237-1243.
  • 3杨华,石梅,王建华,肖锋,罗山泉,谭丽娜,龙晓丽,刘晓莉,许林.局部晚期头颈鳞癌调强放疗联合手术或化疗的疗效分析[J].中华放射肿瘤学杂志,2012,21(4):338-339. 被引量:3
  • 4张昊,韩俊庆,杨哲,穆学茹,赵红莉,王鹏.头颈部鳞癌术后同步放化疗的临床疗效观察[J].山东大学学报(医学版),2009,47(4):105-108. 被引量:3
  • 5Ling W,Mijiti A,Moming A,et al.Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue:a retrospective analysis of 210 cases[J].J Oral Maxillofac Surg,2013,71 (4):775-785.
  • 6陈建武,张幸平,郑建清,苏菁菁,吴敏,肖丽华.诱导化疗联合同步放化疗治疗局部晚期头颈部鳞癌的随机对照研究[J].重庆医科大学学报,2011,36(9):1103-1106. 被引量:8
  • 7Iyer NG,Nixon IJ,Palmer F,et al.Surgical management of squamous cell carcinoma of the soft palate:factors predictive of outcome[J].Head Neck,2012,34(8):1071-1080.
  • 8Feng Z,Guo W,Zhang C,et al.CCND1 as a predictive biomarker of neoadjuvant chemotherapy in patients with locally advanced head and neck squamous cell carcinoma[J].PLoS One,2011,6(10):e26399.
  • 9Cho YW,Roh JL,Jung JH,et al.Prediction of posttreament significant body weight loss and its correlation with disease-free survival in patients with oral squamous cell carcinomas[J].Nutr Cancer,2013,65 (3):417-423.
  • 10Nagata M,Nakayama H,Tanaka T,el al.Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma[J].Br J Cancer,2011,105 (9):1322-1230.

二级参考文献14

  • 1张宗敏,唐平章,徐震纲,李庆宏,胡郁华,徐国镇,高黎,屠规益.下咽鳞癌不同治疗方案的临床分析[J].中华肿瘤杂志,2005,27(1):48-51. 被引量:30
  • 2田文栋,曾宗渊,陈福进,伍国号,郭朱明,张诠.202例Ⅲ~Ⅳ期喉鳞癌治疗方法评价及生存分析[J].癌症,2006,25(1):80-84. 被引量:15
  • 3洪继东,涂青松,廖遇平,申良方,姜武忠,朱红,周蓉蓉.下咽癌120例临床疗效的回顾性分析[J].实用预防医学,2006,13(3):528-530. 被引量:10
  • 4高云生,胡超苏.头颈部鳞癌的术后放疗[J].中国癌症杂志,2007,17(4):344-348. 被引量:5
  • 5高春玲,高春丽,宋维芳,谢立青.放射增敏剂的增敏机制[J].现代肿瘤医学,2007,15(6):890-892. 被引量:5
  • 6Taguchi T, Tsukuda M, Mikami Y, et al. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx[ J]. Aeta Otolaryngol, 2006, 126(4) :408-413.
  • 7Lee N, Chan K. Zhung J, et al. Preliminary results of concurrent chemotherapy with intensity-modulated radiation therapy (IMRT) for adwced cancer of the larynx/hypopharynx[J]. ASCO Meet Abstra, 2006, 24(18S):5544.
  • 8Teh B S, Monga U, Thomby J, et al. Concurrent chemotherapy and "concomitant boost" radiotherapy for unresectable head and neck cancer[J]. Am J Otolaryngol, 2000, 21(5):306- 311.
  • 9Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer[J]. N Engl J Med, 2004, 350 (19) : 1945-1953.
  • 10Coper J S, Pajak T F, Forastiere A A, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck[J]. N Engl J Med, 2004, 350(19) :1937-1944.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部